The world of life and health sciences is witnessing a transformative shift with generative Artificial Intelligence (AI). This technology is not only revolutionizing the way we approach scientific research and laboratory science but is also reshaping the landscape of scientific equipment and instruments.
Generative AI is making significant strides in the life and health sciences sector, with new applications and developments emerging at a rapid pace. One of the key trends is the use of AI in protein design and engineering. Biotech start-up Cradle, for instance, recently raised $24 million in Series A funding to fast-track protein design using its AI-driven platform. The company's technology is not only speeding up the creation of enzymes, vaccines, and other biological products, but it's also addressing global health and environmental challenges. This development signifies a strategic expansion in the biotech sector, with Cradle's generative AI platform demonstrating its ability to double the pace of project progression compared to industry benchmarks.
This week, we’ve invited Product Manager Seb May and Head of Software Engineering Toby Stephens to discuss Delfy, a BC start-up tech company developing a cutting edge AI-tool of the same name to empower businesses.
The rise of AI has taken the world into a new and exciting direction. Tasks that previously took hours can now be completed in a fraction of the time, boosting productivity and freeing up resources to reach milestones and accomplish goals faster than ever before.
At Researcher, we’ve always chased innovative and exciting solutions for scientists: from our mobile app that helps keep up with scientific literature, to the Researcher Live platform for online events, and the in-house magazine Researcher Insights. With the growing accessibility of sophisticated language model technology, we are once again offering our community of academics a way to ease the burden of administrative and repetitive tasks.
Introducing Researcher Toolbox – an all-in-one online platform, here to assist with monotonous daily responsibilities: checking citations in a manuscript, comparing articles from the literature, querying content, drafting lecture plans, grant proposals, transcribing audio files of talks, and more.
AI in Biotech: A Revolutionary Leap Forward
The integration of artificial intelligence (AI) in biotech is not just a game-changer; it's the dealer reshuffling the entire deck. We're talking about a seismic shift that's redefining the boundaries of what's possible in healthcare and medicine. AI isn't just streamlining processes; it's rewriting the rule book. From gene editing marvels like CRISPR to the uncharted territories of prime editing, AI is the new alchemist, turning data into gold.
Today we are speaking to Dr Layla Hosseini-Gerami, co-founder of Ignota Labs - an exciting new start-up company aimed at rescuing distressed pharmaceutical assets using Explainable AI .
In the spirit of holiday festivities, we are reaching out to our newsletter subscribers to let you know about our popular Researcher Toolbox offer.
Researcher Toolbox is an AI-powered platform that helps academics with their citations checks, manuscript writing, summarising, comparing and interrogating academic papers. Toolbox will help you plan your lectures, conference and grant proposals - even draft your social media posts for you by sing your own manuscripts and documents as well as external sources of your choosing.
We have opened a limited number of Ambassador spaces for our GenAI Newsletter readers - fill in this form and take part in our exclusive Toolbox pre-launch programme. By enrolling, you'll be given free access for the entirety of our beta trial, after which you'll receive discounted access of £1/month forever. All we ask is that you give us genuine feedback and help us spread the word about Toolbox.
Generative AI (GenAI) is rapidly transforming scientific research - not only accelerating scientific discovery but also reshaping traditional business operations, as highlighted in a recent report by Deloitte US. Life sciences companies that leverage GenAI to transform end-to-end processes are finding themselves with a competitive edge. In the early stage of GenAI adoption, speed is of the essence. Companies that implement GenAI solutions swiftly are likely to extract immediate value and gain a significant advantage over competitors - with promising results already seen in several key sectors.
